PHARMACYTE BIOTECH, INC. Selling and Marketing Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Selling and Marketing Expense of $0 for the 12-month period ending 2016-04-30, per its 10-K filed 2016-07-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2016-07-29
- PHARMACYTE BIOTECH, INC. selling and marketing expense for the quarter ending 2016-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for the quarter ending 2016-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for the quarter ending 2015-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for the quarter ending 2015-07-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for fiscal 2015 was $230.50K, a 73.57% decline from fiscal 2014.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for fiscal 2014 was $872.20K, a 719.64% increase from fiscal 2013.
- PHARMACYTE BIOTECH, INC. selling and marketing expense for fiscal 2013 was $106.41K, a 854.38% increase from fiscal 2012.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 |
| 2016-01-31 | $0.00 10-Q · filed 2016-03-08 | $0.00 derived: sum of 2 quarters · filed 2016-03-08 | $0.00 10-Q · filed 2016-03-08 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-10-31 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-07-31 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $230.50K 10-K · filed 2016-07-29 |
| 2015-01-31 | $0.00 10-Q · filed 2016-03-08 | $0.00 derived: sum of 2 quarters · filed 2016-03-08 | $230.50K 10-Q · filed 2016-03-08 | $778.10K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-10-31 | $0.00 10-Q/A · filed 2016-01-19 | $230.50K 10-Q/A · filed 2016-01-19 | $778.10K derived: sum of 3 quarters · filed 2016-07-29 | $1.09M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-07-31 | $230.50K 10-Q/A · filed 2016-01-19 | $778.10K derived: sum of 2 quarters · filed 2016-07-29 | $1.09M derived: sum of 3 quarters · filed 2016-07-29 | $1.09M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-04-30 | $547.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $857.20K derived: sum of 2 quarters · filed 2016-07-29 | $857.20K derived: sum of 3 quarters · filed 2016-07-29 | $872.20K 10-K · filed 2016-07-29 |
| 2014-01-31 | $309.60K 10-Q · filed 2015-03-13 | $309.60K derived: sum of 2 quarters · filed 2015-03-13 | $324.60K 10-Q · filed 2015-03-13 | $335.85K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-10-31 | $0.00 10-Q · filed 2014-12-15 | $15.00K 10-Q · filed 2014-12-15 | $26.25K derived: sum of 3 quarters · filed 2016-01-19 | $26.25K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-07-31 | $15.00K 10-Q · filed 2014-09-15 | $26.25K derived: sum of 2 quarters · filed 2016-01-19 | $26.25K derived: sum of 3 quarters · filed 2016-01-19 | $39.43K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-04-30 | $11.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $11.25K derived: sum of 2 quarters · filed 2016-01-19 | $24.43K derived: sum of 3 quarters · filed 2016-01-19 | $106.41K 10-K/A · filed 2016-01-19 |
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $13.18K derived: sum of 2 quarters · filed 2014-03-17 | $95.16K 10-Q · filed 2014-03-17 | -$22.42K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $13.18K 10-Q · filed 2013-12-16 | $95.16K 10-Q · filed 2013-12-16 | -$22.42K derived: sum of 3 quarters · filed 2013-12-16 | -$22.42K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | $81.98K 10-Q · filed 2013-09-16 | -$35.60K derived: sum of 2 quarters · filed 2013-09-16 | -$35.60K derived: sum of 3 quarters · filed 2013-09-16 | -$32.00K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | -$117.58K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$117.58K derived: sum of 2 quarters · filed 2013-07-29 | -$113.98K derived: sum of 3 quarters · filed 2013-07-29 | $11.15K 10-K · filed 2013-07-29 |
| 2012-01-31 | $0.00 10-Q · filed 2013-03-26 | $3.60K derived: sum of 2 quarters · filed 2013-03-26 | $128.73K 10-Q · filed 2013-03-26 | $131.56K derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | $3.60K 10-Q · filed 2012-12-26 | $128.73K 10-Q · filed 2012-12-26 | $131.56K derived: sum of 3 quarters · filed 2012-12-26 | $132.56K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | $125.13K 10-Q · filed 2012-09-19 | $127.95K derived: sum of 2 quarters · filed 2012-09-19 | $128.96K derived: sum of 3 quarters · filed 2012-09-19 | $128.96K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | $2.83K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $3.83K derived: sum of 2 quarters · filed 2012-08-14 | $3.83K derived: sum of 3 quarters · filed 2012-08-14 | $10.83K 10-K · filed 2012-08-14 |
| 2011-01-31 | $1.00K 10-Q · filed 2012-03-21 | $1.00K derived: sum of 2 quarters · filed 2012-03-21 | $8.01K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | $0.00 10-Q · filed 2011-12-15 | $7.00K 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | $7.00K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |